Bats a Source of MERS?

A fragment of viral RNA isolated from an Egyptian tomb bat matches viral RNA isolated from the first human victim of the novel coronavirus.

Written byKate Yandell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

MERS coronavirusNIAIDResearchers may have found a source for the first reported human case of Middle East respiratory syndrome (MERS), which is caused by a coronavirus that has infected more than 100 people in the region and killed 49. A sequence fragment derived from an Egyptian tomb bat matches viral RNA isolated from a Saudi Arabian man who died from the virus in June 2012, according to a report published this week in Emerging Infectious Diseases.

The 182-nucleotide fragment was found in a fecal sample from a bat of the species Taphozous perforatus, which was captured within 7.5 miles of the victim’s home. The bat-derived sequence was identical to the corresponding section of viral RNA isolated from the victim.

But some researchers note that the short stretch of nucleotides is not enough to establish that the bat- and human-derived viruses are one and the same. Marion Koopmans, an epidemiologist at the National Institute for Public Health and the Environment in the Netherlands, told ScienceNOW that the findings indicate that bats are a reservoir of the virus. However, she added, the RNA snippet comes from a relatively non-variable region of the viral genome.

“There’s still potential for it to be relatively distant ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies